Antidotes and poisoning medical products, part 2 / 2024-2025

Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Antidotes and poisoning medical products (part 2) to the rescEU project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in nine (9) lots. Tender may be submitted for one or several lots. - LOT 1: Naloxone 1 mg/ml (2 ml per pre-filled syringe, ATC V03AB15) - LOT 2: Naloxone 0,4 mg/ml (1 ml per vial/ampoule, ATC V03AB15) - LOT 3: Sodiumthiosulfate 25 % (100 ml per vial/ampule, ATC V03AB06) - LOT 4: Physostigmine 2 mg/5 ml (5 ml per vial/ampoule, ATC V03AB19) - LOT 5: Ethanol 95 – 96 % / 20 ml (20 ml per vial/ampoule, ATC V03AB16) - LOT 6: Silibinin (350 mg powder for i.v. / vial, ATC V03AX) - LOT 7: Atropine sulphate 10 mg/ml (10 ml per vial/ampoule, ATC A03BA01) - LOT 8: Pegfilgrastim 6 mg/0,6 ml (0,6 ml per vial/ampoule/prefilled syringe, ATC L03AA13) - LOT 9: Naloxone / single dose container (no further device assembly is required, ATC V03AB15) All products are for CBRN poisoning treatment or CBRN antidotes. The minimum requirements for the articles is described in Annex 1.1. The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Estimated quantity for the product in described in Annex 6 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 6, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The Supplier is not obliged to deliver the Articles under the Option. Please note that all times given in the Call for Tenders refer to local time in Finland. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract Annex 3 Security annex Annex 4 Description of the Handi service Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Estimated quantity (restricted, TL IV) Annex 7 Confidentiality commitment Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.

The availability for the Annex 6 is restricted to security classification level IV, TL IV. THL will send the restricted Annex 6 to a representative of the tenderer via encrypted email after THL has received the signed confidentiality commitment (Annex 7). Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/236/2.02.06/2024 / Antidotes and poisoning medical products, part 2". The message shall contain name of the tenderer and email address to which the restricted Annex 6 is to be sent.

In the case of "LOT 8: Pegfilgrastim 6 mg/0,6 ml (0,6 ml per vial/ampoule, ATC L03AA13)", the pharmaceutical form "prefilled syringe" has not been indicated in the original Call for tenders. Prefilled syringe is also an acceptable pharmaceutical form for LOT 8, which is why it has been added to the Call for tenders. The procurement documents have been amended to reflect this change. The deadline for submitting additional questions has been extended until 14/02/2024, 12:00 (GMT+2).